Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121097792 | 12109779 | 2 | F | 20140417 | 20160627 | 20160224 | 20160704 | EXP | BR-JNJFOC-20160217902 | JANSSEN | 64.10 | YR | A | M | Y | 0.00000 | 20160704 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121097792 | 12109779 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 125261 | 45 | MG | SOLUTION FOR INJECTION | /wk | ||||||
| 121097792 | 12109779 | 2 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 121097792 | 12109779 | 3 | C | THIAZIDE | UNSPECIFIED INGREDIENT | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121097792 | 12109779 | 1 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121097792 | 12109779 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121097792 | 12109779 | Arthritis | |
| 121097792 | 12109779 | Inappropriate schedule of drug administration | |
| 121097792 | 12109779 | Off label use | |
| 121097792 | 12109779 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121097792 | 12109779 | 1 | 20140417 | 0 |